全球研究格局和格雷夫斯病的新兴趋势:图书识别分析
Yan Yang1,2, Peijin Li1,3, Chunjian Zhou4
1Department of Thyropathy, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Medicine
|June 14, 2024
概括
这种图书统计分析揭示了Graves病的关键研究趋势,Graves病是甲状腺功能障碍的常见原因. 该研究强调了临床管理,自身免疫和眼科医疗作为主要研究领域,为未来的研究提供了洞察力.
科学领域:
- 内分泌学 在内分泌学.
- 图书统计学 图书统计学
- 医学研究 分析 分析
背景情况:
- 格雷夫斯病是甲状腺功能障碍的主要原因,对其流行病学,发病因,诊断和治疗进行了广泛的研究.
- 尽管取得了显著的进展,但对格雷夫氏病研究缺乏全面的文献计量分析.
- 本研究通过分析出版趋势和研究焦点来解决这一差距.
研究的目的:
- 从2003年到2023年对格雷夫斯病研究进行全面的文献分析.
- 识别关键趋势,有影响力的出版物,多产的作者和该领域的领先机构.
- 绘制格雷夫氏病研究进展和焦点的地图.
主要方法:
- 从科学网络数据库 (2003-2023) 中检索的10901篇出版物的图书统计分析.
- 利用CiteSpace和R包Bibliometrix进行数据挖掘和综合分析.
- 检查的出版物量,国家/机构贡献,作者生产力,引用影响和关键词聚类.
主要成果:
- 美国在出版量方面处于领先地位,加利福尼亚大学系统是主要贡献者.
- 甲状腺和临床内分泌和新陈代谢杂志是出版和引用的关键期刊.
- 研究热点包括临床管理,甲状腺刺激激素受体,自身免疫,格雷夫斯眼病,甲状腺结节和甲状腺癌.
结论:
- 这是关于格雷夫氏病研究的第一个全面的文献统计研究,总结了其进展和趋势.
- 这些发现突出了当前的研究热点,并确定了有前途的未来方向.
- 这项研究为研究格雷夫斯病领域的研究人员提供了宝贵的参考.
相关概念视频
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
Genomics
36.3K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


